TO SEE EFFECT OF PATHA CHURNA TABLETS IN FEMALES HAVING YONI KANDU

Randomized controlled clinical trial of patha churna vati in yoni kandu in kaphaj yonivyapad wsr candidiasis - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087722

Enrollment

Registered

2025-05-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N761- Subacute and chronic vaginitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Yoni kandu Yoni strava Yonigat toda

Exclusion criteria

Exclusion criteria: Patients having excessive yoni toda Pregnant women Patients previously diagnosed with HIV HBSAG VDRL

Design outcomes

Primary

Measure	Time frame
Reduce symptoms of yoni kandu yoni strava and yonigat toda within 7 days of start of treatmentTimepoint: 7 days	—

Secondary

Measure	Time frame
No recurrence of yoni kanduTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Varsha Suresh Deshmukh

Shree Saptashrungi ayurved mahavidyalay and hospital Kamalnagar Hirawadi Panchavati Nashik

varshasdeshmukh15@gmail.com9403513983

Outcome results